Compugen and Biosite Announce Diagnostic Collaboration
Both companies announced today a collaboration for the development and
commercialization of diagnostic products. Under the agreement, Biosite
is licensed to develop and commercialize immunoassay based diagnostic
products using novel biomarkers discovered by Compugen. Using its
genomic platform and other proprietary computational tools, Compugen
is expected to provide Biosite with comprehensive data on several gene
targets to be nominated by Biosite.
Compugen and Biosite Announce Diagnostic Collaboration
posted by EDITOR @ 11:20 AM 0 comments links to this post
0 Comments:
Post a Comment
Links to this post:
No comments:
Post a Comment